Summary & Overview
HCPCS Level II J1094: Injection, Dexamethasone Acetate 1 mg
HCPCS Level II code J1094 identifies an injection of dexamethasone acetate, 1 mg. This code matters nationally because it is the standardized identifier payers and providers use to report and adjudicate billing for a commonly used injectable corticosteroid in outpatient and ambulatory settings. Consistent coding supports accurate claims processing, inventory tracking, and utilization management for a medication with broad clinical applications in inflammation and allergic conditions.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical context and typical sites of service, along with payer coverage patterns where available. The publication outlines benchmarking elements and policy-relevant considerations for claims submission and compliance, and highlights the types of benchmarks and updates readers can expect in the full report.
This summary is intended for national audiences including provider billing teams, revenue cycle managers, and policy analysts who need a clear, actionable description of what J1094 represents, which payers are included in comparative coverage, and what further details (benchmarks, policy updates, and clinical context) are available in the complete publication. Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
HCPCS Level II code J1094 represents an injection of dexamethasone acetate, 1 mg. This code describes the single-drug injectable formulation and is used to report the administration or supply of that specific medication when required by payer billing rules.
Service Type: Injectable corticosteroid medication
Typical Site of Service: Outpatient clinic, physician office, or ambulatory care setting
Data not available in the input for taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 62-year-old woman with chronic inflammatory joint pain presents to an outpatient orthopedic clinic for targeted intra-articular corticosteroid injection. After clinical evaluation and review of conservative therapies, the provider plans a single dose injection of dexamethasone acetate to a painful knee joint to reduce inflammation and improve function. The workflow includes review of indications and contraindications, informed consent, verification of allergies and anticoagulation status, positioning and sterile prep of the joint, ultrasound guidance as needed, administration of J1094 (injection, dexamethasone acetate, 1 mg), observation for immediate adverse effects, documentation of dose, lot number, and site, and scheduling follow-up for outcome assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
50 | Bilateral procedure | Use when identical injections are performed on both paired joints during the same encounter and payer allows bilateral reporting. |
| SH | Left hand | Use when the injection is specifically performed on the left hand (site-specific modifier set for multi-site reporting where applicable).
| LT | Left side | Use when the procedure is performed on the left side of the body (e.g., left knee) and the payer requires laterality reporting.